News

âš¡COVID-19 Vaccine Update: Zydus Cadila to Begin Phase-2 Clinical Trials of ZyCoV-D From August 6

By IANS

Drug firm Zydus Cadila on Wednesday announced that its plasmid DNA vaccine to prevent COVID-19 -- ZyCoV-D -- was found to be safe and well tolerated in the phase I clinical trial. The company will now commence phase II clinical trials from August 6.

Read Full Story